EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Acupotomy Combined with Celecoxib and Zhenggu Shenjin Capsules for Lumbar Disc Herniation: A Propensity Score-Matched Retrospective Cohort Study

Xiuchen Sun, Shuaimei Zhang, Shuojun Liu

Journal of Pain Research · 2026-04 · Volume 19 · 1-15

DOI: 10.2147/jpr.s594368 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Pain Research, 2026-04. Verfasst von Xiuchen Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pain Clinic, Shandong Wendeng Orthopedics Hospital, Weihai, Shandong, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lumbar disc herniation (LDH) is a leading cause of chronic low back pain, affecting approximately 1-3% of the general population annually with substantial socioeconomic burden. Acupotomy, a minimally invasive Traditional Chinese Medicine (TCM) technique, has demonstrated promise in musculoskeletal disorders, yet large-scale evidence evaluating its combination with pharmacotherapy remains limited. This study evaluated the efficacy and safety of acupotomy combined with celecoxib and Zhenggu Shenjin capsules versus pharmacotherapy alone in patients with LDH.

Methods

This retrospective cohort study analyzed electronic medical records of 800 LDH patients treated at Shandong Wendeng Orthopedic Hospital between February 2023 and October 2024. Using 1:1 propensity score matching (PSM), patients were allocated to the experimental group (acupotomy plus celecoxib 200 mg twice daily and Zhenggu Shenjin capsules 0.99 g three times daily for 4 weeks, n=400) or the control group (celecoxib 200 mg twice daily and Zhenggu Shenjin capsules 0.99 g three times daily without acupotomy, n=400). Primary outcomes included Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) changes at 3 months post-treatment. Secondary outcomes encompassed overall efficacy rates and adverse events (AEs).

Results

Following PSM, baseline characteristics were well-balanced (all standardized mean differences

Schlagwörter

Stichwörter der Autor:innen

acupotomycelecoxiblumbar disc herniationpropensity score matchingretrospective cohort studytraditional Chinese medicinezhenggu shenjin capsules

Autor:innen und Institutionen

  • Pain Clinic, Shandong Wendeng Orthopedics Hospital, Weihai, Shandong, People's Republic of China.
  • Department of Emergency, Shandong Wendeng Orthopedics Hospital, Weihai, Shandong, People's Republic of China.
  • Department of Science and Education, Shandong Wendeng Orthopedics Hospital, Weihai, Shandong, People's Republic of China.

Zitieren

APA

Sun, X., Zhang, S., & Liu, S. (2026). Acupotomy Combined with Celecoxib and Zhenggu Shenjin Capsules for Lumbar Disc Herniation: A Propensity Score-Matched Retrospective Cohort Study. Journal of Pain Research, Volume 19, 1-15. https://doi.org/10.2147/jpr.s594368

Vancouver

Sun X, Zhang S, Liu S. Acupotomy Combined with Celecoxib and Zhenggu Shenjin Capsules for Lumbar Disc Herniation: A Propensity Score-Matched Retrospective Cohort Study. Journal of Pain Research. 2026;Volume 19:1-15. doi:10.2147/jpr.s594368

BibTeX
@article{Sun2026,
  author = {Sun, Xiuchen and Zhang, Shuaimei and Liu, Shuojun},
  title = {Acupotomy Combined with Celecoxib and Zhenggu Shenjin Capsules for Lumbar Disc Herniation: A Propensity Score-Matched Retrospective Cohort Study},
  journal = {Journal of Pain Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--15},
  doi = {10.2147/jpr.s594368}
}
Kostenlos starten →